Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Steinberg

Showing results (921-930 of 1,520) with videos related to

Pageof 152
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumorsP C Adamson, S Zimm, A H Ragab, et al.
Cancer Research|September 1, 1996
Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptorH I Pass, D J Mew, M Carbone, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemiaP C Adamson, S Zimm, A H Ragab, et al.
Cancer|June 22, 2010
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancerChristina M Annunziata, Helene Tuft Stavnes, Lilach Kleinberg, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 21, 2013
Clonal immortalized human glial cell lines support varying levels of JC virus infection due to differences in cellular gene expressionMichael W Ferenczy, Kory R Johnson, Shannon M Steinberg, et al.
Blood|July 16, 2014
A prospective study of mediastinal gray-zone lymphomaWyndham H Wilson, Stefania Pittaluga, Alina Nicolae, et al.
Journal of the National Cancer Institute|January 5, 1994
Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancerE C Kohn, G Sarosy, A Bicher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2011
Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosisEddie A James, James A DeVoti, David W Rosenthal, et al.
The Breast Journal|February 15, 2002
Biomarker assays in nipple aspirate fluidP Klein, E Glaser, L Grogan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1996
Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphomaR M Giusti, E M Maloney, B Hanchard, et al.
Pageof 152

Showing results (921-930 of 1,520) with videos related to

Sort By:
Pageof 152
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumorsP C Adamson, S Zimm, A H Ragab, et al.
Cancer Research|September 1, 1996
Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptorH I Pass, D J Mew, M Carbone, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemiaP C Adamson, S Zimm, A H Ragab, et al.
Cancer|June 22, 2010
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancerChristina M Annunziata, Helene Tuft Stavnes, Lilach Kleinberg, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 21, 2013
Clonal immortalized human glial cell lines support varying levels of JC virus infection due to differences in cellular gene expressionMichael W Ferenczy, Kory R Johnson, Shannon M Steinberg, et al.
Blood|July 16, 2014
A prospective study of mediastinal gray-zone lymphomaWyndham H Wilson, Stefania Pittaluga, Alina Nicolae, et al.
Journal of the National Cancer Institute|January 5, 1994
Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancerE C Kohn, G Sarosy, A Bicher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2011
Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosisEddie A James, James A DeVoti, David W Rosenthal, et al.
The Breast Journal|February 15, 2002
Biomarker assays in nipple aspirate fluidP Klein, E Glaser, L Grogan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1996
Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphomaR M Giusti, E M Maloney, B Hanchard, et al.
Pageof 152